Metildi, CA, Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer. ANN SURG ONCOL. 2014. This evidence concerns the gene CEACAM5 and pancreatic neoplasm.